Bradbury Daniel's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Apr 8, 2024
- Accession no.
- 0001447362-24-000037
- Filed
- Apr 8, 2024
- Trade date
- Apr 4-5, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions. Open-market sales total $441.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bradbury DanielCIK 0001236397 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2024 | Common Stock | SSaleDisposed | −2,901 | $21.45F2 | −$62,226.45 | 47,008 | Indirect | |
| Apr 4, 2024 | Common Stock | SSaleDisposed | −3,125 | $21.45F2 | −$67,031.25 | 22,782 | Indirect | |
| Apr 4, 2024 | Common Stock | SSaleDisposed | −3,126 | $21.45F2 | −$67,052.7 | 22,789 | Indirect | |
| Apr 5, 2024 | Common Stock | SSaleDisposed | −3,731 | $20.86F6 | −$77,828.66 | 43,277 | Indirect | |
| Apr 5, 2024 | Common Stock | SSaleDisposed | −4,019 | $20.86F6 | −$83,836.34 | 18,763 | Indirect | |
| Apr 5, 2024 | Common Stock | SSaleDisposed | −4,021 | $20.86F6 | −$83,878.06 | 18,768 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $21.18 to $21.84, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $20.76 to $21.23, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.